Table 3.
Predictive imaging markers of surgical resection and transplantation
| Treatment | Reference | Study design | No. of patients | Follow-up duration | Poor predictive imaging finding | Primary outcome |
|---|---|---|---|---|---|---|
| Surgical resection | Shin et al [63] | Retrospective, single-center | 281 | 2 years | LR-M compared to LR-4/5, largest tumor size of ≥ 3 cm | Early recurrence |
| Surgical resection | Jiang et al [65] | Retrospective, single-center | 532 | 1 to 11 years | Tumor size, arterial phase hyperenhancement | HCC recurrence |
| Surgical resection | Wei et al [38] | Retrospective, single-center | 103 | Median of 22.1 months | Corona enhancement, peritumoral hypointensity on hepatobiliary phase, satellite nodule | Early recurrence |
| Surgical resection | Wei et al [31] | Retrospective, single-center | 111 | Median of 22.1 months | Blood products in mass, corona enhancement | Recurrence |
| Surgical resection | Zhang et al [67] | Retrospective, single-center | 82 | 1 year | Corona enhancement, irregular tumor margin | Early recurrence |
| Surgical resection | Chen et al [68] | Retrospective, single-center | 149 | 3 years | Multifocal tumors, absence of fat in mass, nonsmooth tumor margin | Recurrence |
| Surgical resection | Bae et al [39] | Retrospective, single-center | 183 | Median of 51 months | Large tumor size on hepatobiliary phase | Disease-free survival, overall survival |
| Liver transplant | Lee et al [64] | Retrospective, multicenter | 140 | 7 years | LR-M compared to LR-4/5 | Recurrence-free survival |